Lexaria Bioscience Corp. (LEXX)
NASDAQ: LEXX · Real-Time Price · USD
2.320
+0.130 (5.94%)
Nov 7, 2024, 4:00 PM EST - Market closed
Lexaria Bioscience Cash Flow Statement
Financials in millions USD. Fiscal year is September - August.
Millions USD. Fiscal year is Sep - Aug.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | May '24 May 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 | Aug '21 Aug 31, 2021 | Aug '20 Aug 31, 2020 | Aug '19 Aug 31, 2019 | 2018 - 2014 |
| Net Income | -4.85 | -6.66 | -7.27 | -4.03 | -3.93 | -4.1 | Upgrade
|
| Depreciation & Amortization | 0.17 | 0.19 | 0.14 | 0.15 | 0.15 | 0.06 | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.16 | 0.11 | - | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | 0.22 | 0.22 | 0.76 | 0.17 | 0.04 | 0.02 | Upgrade
|
| Stock-Based Compensation | 0.41 | 0.17 | 1.95 | 1.28 | 1.41 | 0.91 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | - | 0.05 | 0.05 | 0.08 | Upgrade
|
| Other Operating Activities | -0.02 | -0.05 | -0.12 | -0.15 | -0.13 | -0.05 | Upgrade
|
| Change in Accounts Receivable | -0.08 | 0.03 | -0.14 | 0.19 | -0.09 | -0.14 | Upgrade
|
| Change in Inventory | - | 0.04 | -0 | 0.1 | 0 | -0.05 | Upgrade
|
| Change in Accounts Payable | -0.89 | 0.09 | 0.05 | 0.01 | -0.05 | 0.1 | Upgrade
|
| Change in Unearned Revenue | - | - | - | -0.04 | 0.04 | - | Upgrade
|
| Change in Other Net Operating Assets | 0.2 | -0.01 | -0.26 | -0.19 | -0.1 | 0.17 | Upgrade
|
| Operating Cash Flow | -4.69 | -5.88 | -4.88 | -3.99 | -2.62 | -3.01 | Upgrade
|
| Capital Expenditures | - | -0.03 | -0.05 | - | - | -0.65 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | 0.27 | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -0.19 | -0.14 | -0.13 | -0.08 | -0.03 | -0.12 | Upgrade
|
| Investment in Securities | - | - | - | - | 0.01 | - | Upgrade
|
| Investing Cash Flow | -0.19 | -0.17 | -0.18 | 0.19 | -0.03 | -0.77 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 0.03 | - | Upgrade
|
| Long-Term Debt Repaid | - | - | -0.04 | -0.07 | -0.04 | - | Upgrade
|
| Total Debt Repaid | - | - | -0.04 | -0.07 | -0.04 | - | Upgrade
|
| Net Debt Issued (Repaid) | - | - | -0.04 | -0.07 | -0.01 | - | Upgrade
|
| Issuance of Common Stock | 10.19 | 1.59 | - | 13.49 | 2.67 | 2.33 | Upgrade
|
| Other Financing Activities | - | - | - | - | - | 1 | Upgrade
|
| Financing Cash Flow | 10.19 | 1.59 | -0.04 | 13.42 | 2.65 | 3.33 | Upgrade
|
| Net Cash Flow | 5.3 | -4.46 | -5.1 | 9.62 | 0.01 | -0.44 | Upgrade
|
| Free Cash Flow | -4.69 | -5.91 | -4.93 | -3.99 | -2.62 | -3.65 | Upgrade
|
| Free Cash Flow Margin | -1140.83% | -2614.84% | -1929.75% | -552.02% | -831.91% | -1640.42% | Upgrade
|
| Free Cash Flow Per Share | -0.45 | -0.89 | -0.84 | -0.91 | -0.94 | -1.41 | Upgrade
|
| Cash Income Tax Paid | - | -0.01 | 0 | 0.02 | -0.01 | 0.01 | Upgrade
|
| Levered Free Cash Flow | -3.21 | -3.71 | -2.3 | -2.37 | -1.21 | -2.07 | Upgrade
|
| Unlevered Free Cash Flow | -3.21 | -3.71 | -2.3 | -2.37 | -1.21 | -2.07 | Upgrade
|
| Change in Net Working Capital | 0.68 | -0.18 | 0.08 | 0.16 | 0.14 | -0.22 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.